AFP and metabolic dysfunction-associated steatotic liver disease: However, among patients with NAFLD-related HCC, a higher proportion of AFP non-secretors has been reported and in most HCC cases occurring on a background of fatty liver disease or steatohepatitis, the serum levels of AFP were is low [13,50], an observation often suggestive of a less aggressive tumor biology [116,117].